Merck Defends Inaction on Vioxx VIGOR Data, Cites Naproxen Heart Benefit
This article was originally published in The Tan Sheet
Executive Summary
Merck continues to support the cardioprotective effect of the non-steroidal anti-inflammatory drug naproxen